Allergan stock slips despite revenue beat, a sign of investors’ worries over company’s future

Allergan posts quarterly results that top estimates, but the company’s stock has struggled as generic competition ramps up.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.